Targeting Beta-cell Failure in Lean Patients With Type 2 Diabetes

NCT04657939 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Liraglutide
DRUG: Pioglitazone

Sponsor

University of Leeds